SRI Biosciences delivers next-generation drugs, diagnostics and devices to solve unmet medical needs. We work with partners to develop transformative approaches and platforms for the toughest therapeutic problems.
Our innovation strategies are built on more than 50 years of drug development and discovery experience. We’ve refined our ability to repeat biomedical discovery and catalyze innovation into new products.
Ian M. Colrain
President, Biosciences Division
Some of our innovators
Massimiliano de Zambotti
Research Scientist, Human Sleep Research Program, Center for Health Sciences
Our latestView more
Press release July 7, 2021
SRI International enters drug discovery and research collaboration with Sanofi
Researchers will leverage SynFini, SRI’s artificial intelligence and automation platform, to accelerate development of small-molecule drug targets
Announcements July 12, 2021
SRI International’s Parijat Bhatnagar receives DARPA award to continue groundbreaking research…
The prestigious award provides additional funds to continue developing cells that can be stimulated via extracorporeal devices to treat viral infections
Research and development December 8, 2020
The mental health impact of COVID-19 restrictions
How did pandemic isolation and pandemic-related changes affect individuals around the globe?
SRI Biosciences’ highly specialized platforms marry the advantages of our cutting-edge research with our flexible biotech business model. Partner with us to leverage our rigorous early discovery and development to customize your specific applications.
FOX Three Molecular Guidance System™
Cell-selective, intracellular delivery of macromolecular therapeutics: Deliver essentially any cargo to selected cell types, and internalize into those cells to targeted subcellular locations.
Suite of automated tools leverages AI to recreate and scale literature-reported synthesis procedures. Solutions focus on key areas of route design, reaction screening and optimization (RSO), and multi-step synthesis development.
AI-guided precision cancer therapy platform provides a new approach to finding targeted therapies for previously “undruggable mutations.”
There are many talented researchers from various disciplines at SRI. This creates an exciting environment and fertile ground for cutting edge research thanks to the cooperation of different teams. This highly effective collaboration allows SRI to invent and develop unique and novel products and technologies.
Research Scientist, Biosciences Division
Featured publicationsSearch publications
Performance of Fitbit Charge 3 Against Polysomnography in Measuring Sleep in Adolescent Boys and Girls
SRI Authors: Dilara Yüksel, Fiona C Baker, Massimiliano de Zambotti
Article April 1, 2021
Physiological Responses to Acute Psychosocial Stress in Women with Menopausal Insomnia
SRI Authors: Dilara Yüksel, Massimiliano de Zambotti, Tilman Schulte, Ian M. Colrain, Fiona C Baker
Journal Article February 26, 2021
How can we help?
Once you hit send…
We’ll match your inquiry to the person who can best help you. Expect a response within 48 hours.